CAS: 1372540-25-4 - GSK2636771
GSK2636771
CAS:1372540-25-4
Formula:
C22H22F3N3O3
Purity:
98+%
Color and Shape:
Solid
Molecular weight:
433.4236
Ref: AN-AG009CC3
| 1mg | 54.00 € | |
| 5mg | 92.00 € | |
| 10mg | 113.00 € | |
| 50mg | 225.00 € |
Estimated delivery in United States, on Friday 10 May 2024
GSK2636771
CAS:1372540-25-4
GSK2636771, an effective, specific, orally bioavailable, PI3Kβ inhibitor, has been used in cancer, lymphoma, solid …
Formula:
C22H22F3N3O3
Purity:
99.74%
Color and Shape:
Solid
Molecular weight:
433.42
Ref: TM-T2073
| 1mg | 42.00 € | |
| 2mg | 56.00 € | |
| 5mg | 87.00 € | |
| 10mg | 147.00 € | |
| 25mg | 248.00 € | |
| 50mg | 353.00 € | |
| 100mg | 535.00 € | |
| 1ml*10 (DMSO) | 88.00 € |
Estimated delivery in United States, on Friday 17 May 2024
GSK2636771
Controlled ProductCAS:1372540-25-4
Formula:
C22H22F3N3O3
Color and Shape:
Pale Yellow Solid
Molecular weight:
433.42
Ref: TR-G797495
| 2500µg | 195.00 € |
Estimated delivery in United States, on Thursday 20 Jun 2024
![2-Methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylic acid](https://static.cymitquimica.com/products/3D/thumb/FM102909.jpg)
2-Methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylic acid
CAS:1372540-25-4
2-Methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylic acid (BIC) is a strain that is categorized as a cancer drug. It has …
Formula:
C22H22F3N3O3
Purity:
Min. 95%
Molecular weight:
433.42 g/mol
Ref: 3D-FM102909
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire |
Estimated delivery in United States, on Friday 21 Jun 2024
